Literature DB >> 8473543

Cocaine abuse in North America: a milestone in history.

G Das1.   

Abstract

The euphoric effects of coca leaves have been known to mankind for thousands of years. Yet the first epidemic of cocaine use in America occurred during the late 19th century. Initially, there were no laws restricting the consumption or sale of cocaine. In fact, cocaine was freely available in drug stores, saloons, from mail-order vendors, and even in grocery stores. It is reported that one drug manufacturer, in 1885, was selling cocaine in 15 different forms, including cigarettes, cheroots, inhalants, cordials, crystals, and solutions. Many famous imported wines, such as "Vin Mariani," contained a mixture of wine and coca. For consumers on budgets, the wonder drug was available as Coca-Cola and dozens of other soda pops and pick-me-up drinks. One of them even had a simple and direct name, Dope. Soon enough, the ill effects of cocaine became apparent, and by the 1920s cocaine was the most feared of all illicit drugs. Most states began enacting laws against cocaine use. President William Taft proclaimed cocaine as Public Enemy No. 1, and in 1914 the Congress passed the Harrison act, which tightly regulated the distribution and sale of cocaine. By the late 1950s, cocaine use in the United States was simply considered a problem in the past. Unfortunately, the people who were aware of the nation's first cocaine epidemic gradually passed away, and America once again was ready for its fling with cocaine in the 1960s. Today, it is estimated that upwards of 50 million Americans, that is one in four, have used cocaine. In addition, another fifty thousand people use this substance for the first time each day. More than 6 million Americans use cocaine on a regular basis. Little wonder, then, that America as well as the other countries have declared a "War on Drugs." In this review, pharmacology of cocaine, major complications arising from its use, and efforts to curb its abuse are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473543     DOI: 10.1002/j.1552-4604.1993.tb04661.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  9 in total

Review 1.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  How much fire under the smoke? The effects of exposure to cocaine on the fetus.

Authors:  M J Rieder
Journal:  CMAJ       Date:  1994-12-01       Impact factor: 8.262

Review 3.  Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  AAPS J       Date:  2007-01-05       Impact factor: 4.009

4.  An immunochromatographic dipstick as an alternate for monitoring of heroin metabolites in urine samples.

Authors:  Priya Mishra; Ivneet Banga; Roshika Tyagi; Tanya Munjal; Aditya Goel; Neena Capalash; Prince Sharma; C R Suri; Sonu Gandhi
Journal:  RSC Adv       Date:  2018-06-26       Impact factor: 4.036

Review 5.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

Review 6.  Cocaine use and stroke.

Authors:  Sean D Treadwell; Tom G Robinson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 7.  The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.

Authors:  Schuyler A Chambers; Jenna M DeSousa; Eric D Huseman; Steven D Townsend
Journal:  ACS Chem Neurosci       Date:  2018-02-01       Impact factor: 4.418

8.  Trends of Cocaine Use and Manifestations in Hospitalized Patients: A Cross-Sectional Study.

Authors:  Karthik Gangu; Aniesh Bobba; Sanket D Basida; Sindhu Avula; Harleen Chela; Simranjit Singh
Journal:  Cureus       Date:  2022-02-10

9.  Chemiluminescence based immunoassay for the detection of heroin and its metabolites.

Authors:  Smritee Singh; Priya Mishra; Ivneet Banga; Avanish S Parmar; Prem Prakash Tripathi; Sonu Gandhi
Journal:  Bioimpacts       Date:  2017-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.